Aurobindo MD's exit alone may not lift stock, new team must start well

In six weeks of the cancellation of the Rs 420-crore controversial acquisition of Cronus Pharma, a veterinary products company, the managing director of Aurobindo Pharma, India's second-largest pharma company by revenue, is stepping down.

via Economictimes

No comments